vs
欧文斯科宁（OC）与Solventum（SOLV）财务数据对比。点击上方公司名可切换其他公司
欧文斯科宁的季度营收约是Solventum的1.1倍（$2.1B vs $2.0B），Solventum净利率更高（3.2% vs -13.9%，领先17.1%），Solventum同比增速更快（-3.7% vs -24.6%），欧文斯科宁自由现金流更多（$333.0M vs $32.0M），过去两年Solventum的营收复合增速更高（-0.4% vs -3.5%）
欧文斯科宁是美国知名建材及复合材料企业，1935年由康宁玻璃厂与欧文斯-伊利诺伊公司合资组建。主营保温材料、屋面材料、玻璃纤维复合材料及相关产品，是全球最大的玻璃纤维复合材料生产商，全球员工约1.9万人，自1955年《财富》500强榜单创立以来连年上榜。
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
OC vs SOLV — 直观对比
营收规模更大
OC
是对方的1.1倍
$2.0B
营收增速更快
SOLV
高出20.9%
-24.6%
净利率更高
SOLV
高出17.1%
-13.9%
自由现金流更多
OC
多$301.0M
$32.0M
两年增速更快
SOLV
近两年复合增速
-3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.1B | $2.0B |
| 净利润 | $-298.0M | $63.0M |
| 毛利率 | 23.2% | 51.4% |
| 营业利润率 | -10.5% | 6.3% |
| 净利率 | -13.9% | 3.2% |
| 营收同比 | -24.6% | -3.7% |
| 净利润同比 | -15.5% | 103.2% |
| 每股收益（稀释后） | $-3.47 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OCSOLV
| Q4 25 | $2.1B | $2.0B | ||
| Q3 25 | $2.7B | $2.1B | ||
| Q2 25 | $2.7B | $2.2B | ||
| Q1 25 | $2.5B | $2.1B | ||
| Q4 24 | $2.8B | $2.1B | ||
| Q3 24 | $3.0B | $2.1B | ||
| Q2 24 | $2.8B | $2.1B | ||
| Q1 24 | $2.3B | $2.0B |
净利润OCSOLV
| Q4 25 | $-298.0M | $63.0M | ||
| Q3 25 | $-494.0M | $1.3B | ||
| Q2 25 | $363.0M | $90.0M | ||
| Q1 25 | $-93.0M | $137.0M | ||
| Q4 24 | $-258.0M | $31.0M | ||
| Q3 24 | $321.0M | $122.0M | ||
| Q2 24 | $285.0M | $89.0M | ||
| Q1 24 | $299.0M | $237.0M |
毛利率OCSOLV
| Q4 25 | 23.2% | 51.4% | ||
| Q3 25 | 28.2% | 54.2% | ||
| Q2 25 | 31.2% | 54.4% | ||
| Q1 25 | 28.7% | 53.8% | ||
| Q4 24 | 28.1% | 53.9% | ||
| Q3 24 | 29.8% | 56.0% | ||
| Q2 24 | 31.1% | 54.6% | ||
| Q1 24 | 29.6% | 58.1% |
营业利润率OCSOLV
| Q4 25 | -10.5% | 6.3% | ||
| Q3 25 | -12.2% | 80.6% | ||
| Q2 25 | 18.4% | 9.9% | ||
| Q1 25 | 16.1% | 7.3% | ||
| Q4 24 | -8.5% | 6.6% | ||
| Q3 24 | 16.7% | 13.2% | ||
| Q2 24 | 16.4% | 11.7% | ||
| Q1 24 | 17.5% | 18.9% |
净利率OCSOLV
| Q4 25 | -13.9% | 3.2% | ||
| Q3 25 | -18.4% | 60.4% | ||
| Q2 25 | 13.2% | 4.2% | ||
| Q1 25 | -3.7% | 6.6% | ||
| Q4 24 | -9.1% | 1.5% | ||
| Q3 24 | 10.5% | 5.9% | ||
| Q2 24 | 10.2% | 4.3% | ||
| Q1 24 | 13.0% | 11.8% |
每股收益（稀释后）OCSOLV
| Q4 25 | $-3.47 | $0.37 | ||
| Q3 25 | $-5.92 | $7.22 | ||
| Q2 25 | $4.25 | $0.51 | ||
| Q1 25 | $-1.08 | $0.78 | ||
| Q4 24 | $-2.92 | $0.18 | ||
| Q3 24 | $3.65 | $0.70 | ||
| Q2 24 | $3.24 | $0.51 | ||
| Q1 24 | $3.40 | $1.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $345.0M | $878.0M |
| 总债务越低越好 | $4.7B | $5.0B |
| 股东权益账面价值 | $3.9B | $5.0B |
| 总资产 | $13.0B | $14.3B |
| 负债/权益比越低杠杆越低 | 1.22× | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资OCSOLV
| Q4 25 | $345.0M | $878.0M | ||
| Q3 25 | $286.0M | $1.6B | ||
| Q2 25 | $230.0M | $492.0M | ||
| Q1 25 | $400.0M | $534.0M | ||
| Q4 24 | $361.0M | $762.0M | ||
| Q3 24 | $499.0M | $772.0M | ||
| Q2 24 | $254.0M | $897.0M | ||
| Q1 24 | $1.3B | $996.0M |
总债务OCSOLV
| Q4 25 | $4.7B | $5.0B | ||
| Q3 25 | $4.7B | $5.1B | ||
| Q2 25 | $5.1B | $7.8B | ||
| Q1 25 | $5.0B | $7.9B | ||
| Q4 24 | $5.1B | $8.0B | ||
| Q3 24 | $5.0B | $8.1B | ||
| Q2 24 | $5.0B | $8.3B | ||
| Q1 24 | $2.6B | $8.3B |
股东权益OCSOLV
| Q4 25 | $3.9B | $5.0B | ||
| Q3 25 | $4.4B | $5.0B | ||
| Q2 25 | $5.2B | $3.6B | ||
| Q1 25 | $4.9B | $3.3B | ||
| Q4 24 | $5.1B | $3.0B | ||
| Q3 24 | $5.6B | $3.2B | ||
| Q2 24 | $5.5B | $2.9B | ||
| Q1 24 | $5.2B | $3.9B |
总资产OCSOLV
| Q4 25 | $13.0B | $14.3B | ||
| Q3 25 | $13.5B | $14.0B | ||
| Q2 25 | $14.5B | $15.1B | ||
| Q1 25 | $14.3B | $14.5B | ||
| Q4 24 | $14.1B | $14.5B | ||
| Q3 24 | $15.1B | $14.7B | ||
| Q2 24 | $15.0B | $14.6B | ||
| Q1 24 | $11.3B | $14.7B |
负债/权益比OCSOLV
| Q4 25 | 1.22× | 1.00× | ||
| Q3 25 | 1.06× | 1.03× | ||
| Q2 25 | 0.98× | 2.14× | ||
| Q1 25 | 1.03× | 2.43× | ||
| Q4 24 | 1.01× | 2.71× | ||
| Q3 24 | 0.89× | 2.54× | ||
| Q2 24 | 0.92× | 2.90× | ||
| Q1 24 | 0.51× | 2.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $590.0M | $95.0M |
| 自由现金流经营现金流 - 资本支出 | $333.0M | $32.0M |
| 自由现金流率自由现金流/营收 | 15.5% | 1.6% |
| 资本支出强度资本支出/营收 | 12.0% | 3.2% |
| 现金转化率经营现金流/净利润 | — | 1.51× |
| 过去12个月自由现金流最近4个季度 | $962.0M | $-10.0M |
8季度趋势，按日历期对齐
经营现金流OCSOLV
| Q4 25 | $590.0M | $95.0M | ||
| Q3 25 | $918.0M | $76.0M | ||
| Q2 25 | $327.0M | $169.0M | ||
| Q1 25 | $-49.0M | $29.0M | ||
| Q4 24 | $676.0M | $219.0M | ||
| Q3 24 | $699.0M | $169.0M | ||
| Q2 24 | $493.0M | $355.0M | ||
| Q1 24 | $24.0M | $442.0M |
自由现金流OCSOLV
| Q4 25 | $333.0M | $32.0M | ||
| Q3 25 | $752.0M | $-21.0M | ||
| Q2 25 | $129.0M | $59.0M | ||
| Q1 25 | $-252.0M | $-80.0M | ||
| Q4 24 | $479.0M | $92.0M | ||
| Q3 24 | $558.0M | $76.0M | ||
| Q2 24 | $336.0M | $297.0M | ||
| Q1 24 | $-128.0M | $340.0M |
自由现金流率OCSOLV
| Q4 25 | 15.5% | 1.6% | ||
| Q3 25 | 28.0% | -1.0% | ||
| Q2 25 | 4.7% | 2.7% | ||
| Q1 25 | -10.0% | -3.9% | ||
| Q4 24 | 16.9% | 4.4% | ||
| Q3 24 | 18.3% | 3.7% | ||
| Q2 24 | 12.0% | 14.3% | ||
| Q1 24 | -5.6% | 16.9% |
资本支出强度OCSOLV
| Q4 25 | 12.0% | 3.2% | ||
| Q3 25 | 6.2% | 4.6% | ||
| Q2 25 | 7.2% | 5.1% | ||
| Q1 25 | 8.0% | 5.3% | ||
| Q4 24 | 6.9% | 6.1% | ||
| Q3 24 | 4.6% | 4.5% | ||
| Q2 24 | 5.6% | 2.8% | ||
| Q1 24 | 6.6% | 5.1% |
现金转化率OCSOLV
| Q4 25 | — | 1.51× | ||
| Q3 25 | — | 0.06× | ||
| Q2 25 | 0.90× | 1.88× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 7.06× | ||
| Q3 24 | 2.18× | 1.39× | ||
| Q2 24 | 1.73× | 3.99× | ||
| Q1 24 | 0.08× | 1.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OC
| Insulation | $724.0M | 34% |
| Residential | $625.0M | 29% |
| Doors | $427.0M | 20% |
| Discontinued Operations Disposed Of By Sale | $299.0M | 14% |
| Commercial And Industrial Sector | $101.0M | 5% |
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
